Dr Steven Sampson was selected as a principal investigator for an FDA approved study for Recover® Kit for Chronic Elbow Tendinosis using platelet rich plasma (PRP). This study includes up to 10 centers across the country and will hopefully pave the way for FDA approval and widespread use. Stay tuned for further info regarding this and other studies Dr Sampson is involved with in 2009.
www.orthohealing.com
http://www.biomet.com/patients/clinical_recruitment_recover.cfm
Tags: Biomet, Dr Steven Sampson, FDA study, multi center study, platelet rich plasma, prp injection, tendon injury, tendonopathy, tennis elbow
Steven Sampson D.O.
Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.
